REVLIMID® (lenalidomide) Treatment for Multiple Myeloma | Mantle Cell

- revlimid.com

About REVLIMID® (lenalidomide) treatment for deletion 5q myelodysplastic syndromes, mantle cell lymphoma and multiple myeloma including full indications, dosing, administration, efficacy, safety & prescribing information.

3,042,210 $ 480.00